Compare Novavax Inc (NVAX) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Teucrium Soybean Fund — how do they compare? Novavax Inc trades at $9.88 (market cap $1.68B), while Teucrium Soybean Fund trades at $27.66. The key difference: Teucrium Soybean Fund is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | SOYB | |
|---|---|---|
Market Cap | $1.68B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $11.19 | $27.84 |
52-Week Low | $6.22 | $21.46 |
Enterprise Value | $1.26B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $10.19, showing modest daily movement with a -0.29% decline. The stock maintains a bullish technical signal with strong moving average support. Recent quarterly earnings have consistently beaten expectations, though the company faces profitability challenges with a -59.87% net income margin. Positive developments include regulatory approvals for its updated COVID-19 vaccine and progress in the Sanofi partnership, driving investor optimism.
The outlook remains mixed with strong analyst support (74% buy ratings) but significant financial risks. Investment opportunity lies in the company's partnership strategy and Matrix-M adjuvant platform, while risks include cash flow challenges and competitive vaccine market pressures. The stock's low P/E ratio of 3.14 suggests potential undervaluation if operational improvements continue.
SOYB trades at $27.84, up 0.69% today, with a bullish technical signal from moving averages but bearish oscillators. The stock shows strong momentum indicators, with RSI levels indicating overbought conditions. Recent news highlights commodity price trends influencing agricultural stocks.
The outlook remains tied to commodity market dynamics, with potential upside from rising soybean prices but risks from geopolitical tensions and volatility. Investors should weigh technical overbought signals against fundamental growth catalysts in the agricultural sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
